Dr Reddy’s to manufacture baricitinib for Covid -19 treatment in India

Pharma major Dr. Reddy’s Laboratories Ltd on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of baricitinib in India. The drug baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organization (CDSCO), Ministry of Health, India, … Continue reading Dr Reddy’s to manufacture baricitinib for Covid -19 treatment in India